Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neural Mechanisms of Enhancing Emotion Regulation in Bereaved Spouses

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04822194
Recruitment Status : Recruiting
First Posted : March 30, 2021
Last Update Posted : March 2, 2022
Sponsor:
Collaborator:
National Institute on Aging (NIA)
Information provided by (Responsible Party):
Bryan Denny, William Marsh Rice University

Brief Summary:

This study investigates the underlying mechanisms of a novel emotion regulation intervention among recently bereaved spouses. More specifically, this study examines how thinking about an emotional stimulus in a more adaptive way can affect the relationship between psychological stress, psychophysiological biomarkers of adaptive cardiac response, and brain activity. The emotion regulation strategy targeted is reappraisal, specifically reappraisal-by-distancing (i.e., thinking about a negative situation in a more objective, impartial way) versus reappraisal-by-reinterpretation (i.e., thinking about a better outcome for a negative situation than what initially seemed apparent).

The study seeks to determine if relatively brief, focused reappraisal training in bereaved spouses will result in reduction of self-reported negative affect, increases in respiratory sinus arrhythmia (RSA; a measure of heart rate variability reflecting adaptive cardiac vagal tone), reduction in blood-based inflammatory biomarkers, and changes in neural activity over time. Reappraisal-by-distancing is expected to lead to greater changes in these variables relative to reappraisal-by-reinterpretation. Additionally, it is expected that across time decreases in self-reported negative affect, increases in RSA, reductions in blood-based inflammatory biomarker levels, and changes in neural activity will in turn lead to reductions in depressive symptoms and grief rumination. Finally, it is expected that distancing training will lead to reductions in depressive symptoms and grief rumination that are mediated by changes in the targeted neurobiological and behavioral mechanisms.


Condition or disease Intervention/treatment Phase
Affect Bereavement Emotions Depressive Symptoms Grief Behavioral: Cognitive Emotion Regulation Training Not Applicable

Detailed Description:

The objective of this study is to use an experimental medicine approach to evaluate the basic psychological, psychophysiological, and neural mechanisms underlying a novel cognitive emotion regulation intervention aimed at improving psychological outcomes (e.g., reducing depressive symptoms and grief rumination) in recently bereaved spouses. Cognitive reappraisal (i.e. the ability to modify the trajectory of an emotional response by thinking about and appraising emotional information in an alternative, more adaptive way) represents a highly promising target for psychological intervention in bereavement. Reappraisal can be operationalized via two primary tactics: psychological distancing (i.e. appraising an emotional stimulus as an objective, impartial observer) and reinterpretation (i.e. imagining a better outcome than what initially seemed apparent). The current study builds upon promising preliminary work to investigate the effectiveness and underlying neurobiological mechanisms of a novel, five-session cognitive reappraisal intervention in bereaved spouses.

Recently bereaved participants (i.e. approximately 6 months post-spousal loss) will be randomly assigned to receive training in either distancing or reinterpretation, with five sessions occurring every 1-3 days, with longitudinal collection of affective, psychophysiological, physiological (i.e., blood draws to assess inflammatory biomarkers) and functional magnetic resonance imaging (fMRI) data. Follow-up questionnaire assessments will occur at one- and two-months post-intervention. The study aims to mechanistically relate changes in psychological, psychophysiological, physiological, and neural function during a novel emotion regulation intervention never before implemented in this stressed, high risk group. This research represents a Phase I, Stage I clinical trial. The primary endpoints are the assessments of the psychological, psychophysiological, physiological, and neural mechanisms mediating behavior change as a function of the cognitive emotion regulation intervention. The secondary endpoint is testing the efficacy of the intervention via assessment of psychological outcomes (i.e., the behavior change, as represented in changes in depressive symptoms, stress, and grief rumination).

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 84 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Participants will be randomized to either the "Distancing" or "Reinterpretation" group.
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Neural Mechanisms of Enhancing Emotion Regulation in Bereaved Spouses
Actual Study Start Date : February 2, 2022
Estimated Primary Completion Date : April 30, 2022
Estimated Study Completion Date : May 31, 2022

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Distancing
Participants will receive structured cognitive emotion regulation training from an experimenter during an approximately 10-minute interaction in which detailed instructions for implementation of the distancing strategy is explained (i.e. appraising an emotional stimulus as an objective, impartial observer).
Behavioral: Cognitive Emotion Regulation Training
Cognitive emotion regulation training via cognitive reappraisal involves the ability to modify the trajectory of an emotional response by thinking about and appraising emotional information in an alternative, more adaptive way. Reappraisal to down-regulate negative emotion can be operationalized via two tactics: psychological distancing and reinterpretation. The current study will randomly assign participants to receive a brief course of reappraisal training using either psychological distancing or reinterpretation.

Active Comparator: Reinterpretation
Participants will receive structured cognitive emotion regulation training from an experimenter during an approximately 10-minute interaction in which detailed instructions for implementation of the reinterpretation strategy is explained (i.e. imagining a better outcome than what initially seemed apparent).
Behavioral: Cognitive Emotion Regulation Training
Cognitive emotion regulation training via cognitive reappraisal involves the ability to modify the trajectory of an emotional response by thinking about and appraising emotional information in an alternative, more adaptive way. Reappraisal to down-regulate negative emotion can be operationalized via two tactics: psychological distancing and reinterpretation. The current study will randomly assign participants to receive a brief course of reappraisal training using either psychological distancing or reinterpretation.




Primary Outcome Measures :
  1. Change in self-reported negative affect [ Time Frame: At each training session immediately after emotion regulation task, approximately every 2-3 days for 2 weeks. ]
    Self-reported negative affect data collected at the completion of emotion regulation task, with 1 meaning "not negative at all" and 5 meaning "very negative".

  2. Change in respiratory sinus arrhythmia [ Time Frame: At baseline and at final training session, approximately 2 weeks post-baseline ]
    Heart rate variability

  3. Change in neural activity [ Time Frame: During emotion regulation task at baseline and at final training session, approximately 2 weeks post-baseline ]
    Functional magnetic resonance imaging (fMRI) data

  4. Change in grief rumination [ Time Frame: At baseline, final training session (approximately 2 weeks post-baseline), and at 1 and 2 months post-intervention ]
    Grief rumination assessed via Utrecht Grief Rumination Scale (UGRS) and the Inventory for Complicated Grief (ICG). The URGS assesses grief by asking participants to rate how often they have experienced certain thoughts over the past month on a five-point scale ranging from 1 (never) to 5 (very often). Total scores range from 15 to 75, with higher numbers representing higher overall grief rumination. The ICG assesses grief via 19 first-person statements that participants rate on a scale of 1 (Never) to 5 (Always). Higher numbers reflect greater grief.

  5. Change in depressive symptoms [ Time Frame: At baseline, final training session (approximately 2 weeks post-baseline), and at 1 and 2 months post-intervention ]
    Symptoms of depression assessed via the Center for Epidemiological Studies Depression (CES-D) scale, which asks participants to rate how often in the past week they have experience symptoms of depression, ranging from 0 (Rarely or none of the time) to 3 (Most of the time). Scores range from 0 to 60, with higher scores indicating higher levels of depressive symptoms.

  6. Change in perceived stress [ Time Frame: At baseline, final training session (approximately 2 weeks post-baseline), and at 1 and 2 months post-intervention ]
    Perceived stress assessed via the Perceived Stress Scale, which consists of 10 self-reported items asking participants how often they felt or thought a certain way, ranging from 0 (Never) to 4 (Very Often). Higher scores indicate higher levels of perceived stress.


Secondary Outcome Measures :
  1. Frequency of reappraisal usage [ Time Frame: At baseline, final training session (approximately 2 weeks post-baseline), and at 1 and 2 months post-intervention ]
    Overall reappraisal usage frequency assessed via the Emotion Regulation Questionnaire

  2. Physical health [ Time Frame: At baseline, final training session (approximately 2 weeks post-baseline), and at 1 and 2 months post-intervention ]
    Physical health and quality of life assessed via the SF-36

  3. Inflammatory biomarkers [ Time Frame: Prior to baseline and following the final training session (approximately 2 weeks post-baseline) ]
    Inflammatory biomarkers (e.g., IL-1ra, IL-6, IL-6sR, IL-10, and TNF- α) measured via blood draw



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Recent loss of romantic partner within the past 5-7 months
  • At least 18 years of age
  • Minimum score of 25 on the Inventory for Complicated Grief
  • Must be able to speak, read, and write in English
  • Must be eligible to safely complete MRI scanning

Exclusion Criteria:

  • Death of a second close family member/friend in the past year
  • Currently receiving psychotherapy
  • Diagnosed with obstructive pulmonary and/or heart disease, diabetes, liver failure, or kidney failure
  • Significant visual, auditory, or cognitive impairment
  • Divorced within the last year
  • Prior participation in a similar emotion regulation training protocol in Dr. Denny's lab
  • Any contraindication of MRI scanning (e.g., pregnancy, presence of any non-removable metal on or in the body, implanted medical devices, tattoos, medication patches, orthodontic braces or permanent retainers, hearing aids, history of claustrophobia or breathing disorders)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04822194


Contacts
Layout table for location contacts
Contact: Bryan Denny, Ph.D. 713-348-8257 btd3@rice.edu

Locations
Layout table for location information
United States, Texas
Rice University Recruiting
Houston, Texas, United States, 77030
Contact: Mallory L Jungles, BA    713-348-8246    mlj5@rice.edu   
Contact: Bryan T Denny, PhD    713-348-8257    btd3@rice.edu   
Principal Investigator: Bryan T Denny, PhD         
Sponsors and Collaborators
Bryan Denny
National Institute on Aging (NIA)
Investigators
Layout table for investigator information
Principal Investigator: Bryan Denny, Ph.D. William Marsh Rice University
Publications:

Layout table for additonal information
Responsible Party: Bryan Denny, Assistant Professor, William Marsh Rice University
ClinicalTrials.gov Identifier: NCT04822194    
Other Study ID Numbers: IRB-FY2017-90
1R21AG061597-01A1 ( U.S. NIH Grant/Contract )
First Posted: March 30, 2021    Key Record Dates
Last Update Posted: March 2, 2022
Last Verified: February 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: Pursuant to the NIH Data Sharing Policy, we have created a Data Sharing Plan for the proposed research. Under this plan, and pursuant to IRB regulations, fully de-identified raw data (defined below) will be made publicly available. Available data will include a compendium of de-identified training condition assignments; raw (i.e. individual subject-by-condition level) negative affect self-reports; questionnaire data; raw heart rate variability data; and raw subject-level brain data (i.e. unpreprocessed functional and structural MRI data, converted to the widely-sharable Brain Imaging Data Structure [BIDS] standard).
Supporting Materials: Study Protocol
Time Frame: De-identified data will be made available after the analysis process is complete and research manuscripts are finalized. There is no fixed end date for data access.
Access Criteria: Data will be publicly available on OpenNeuro (https://openneuro.org), a free, open- science neuroinformatics data repository.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Bryan Denny, William Marsh Rice University:
emotion regulation
bereavement
affective neuroscience
social cognitive neuroscience
Additional relevant MeSH terms:
Layout table for MeSH terms
Depression
Behavioral Symptoms